Applying technology to personalized breast cancer treatment in Vietnam

On April 20, 2025, nearly 200 domestic and international medical experts attended the scientific conference "Innovation in breast cancer diagnosis and treatment".

Experts say that AI has the potential to impact several parameters of cancer therapy including prediction, screening, analysis and interpretation of huge data sets, decoding tumor imaging data, drug discovery and drug validation in clinical settings. Photo: PQ

This event brings together leading doctors and researchers in the fields of oncology, radiology, diagnostic imaging and surgery, along with representatives of the medical technology group Siemens Healthineers, etc. to update new treatment trends, promote professional cooperation and promote personalized care for breast cancer patients in Vietnam.

The workshop also organized an in-depth discussion with the participation of experts from Siemens Healthineers, MammoCare, K Hospital and Hanoi Medical University.

Topics discussed include: Application of artificial intelligence (AI) in diagnostic imaging, genetic testing in selecting targeted treatment regimens, connecting inter-hospitals in managing breast cancer patients, and the potential for implementing precision medicine in Vietnam.

Experts say that AI has the potential to impact several parameters of cancer therapy including prediction, screening, analysis and interpretation of huge data sets, decoding tumor imaging data, drug discovery and drug validation in clinical settings.

Screening for tumor targets in both healthy and high-risk populations offers the opportunity to detect cancer early and improve the chances of recovery for treatment and cure.

Now with the advancements in AI with machine learning and deep learning are developing rapidly, and will soon change the science of cancer detection and screening. There is a need to train advanced AI technologies to predict cancer early in patients.

Speaking at the opening of the workshop, Dr. Bui Van Chinh, CEO of MammoCare Vietnam, said that we are dealing with many diseases that tend to increase rapidly and become younger, of which cancer is no exception.

According to the Global Cancer Organization (Globocan), by 2040, the cancer incidence rate in Vietnam will increase by about 59.4% and the mortality rate from this disease will be about 70.3%. Especially breast cancer, although this disease mainly occurs in women, is the type of cancer with the highest mortality rate and the highest incidence rate in both sexes.

According to Dr. Chinh, one of the main reasons leading to the mortality rate is late detection, poor awareness, limited technical means, inconsistent professional qualifications and lack of proper social attention to this issue.

Dr. Bui Van Chinh - CEO of MammoCare Vietnam speaking at the conference. Photo: PQ

“Breast cancer is currently the most common cancer in Vietnamese women. Early detection plays a decisive role in the effectiveness of treatment and survival. Through today's workshop, we hope to not only bring advanced technology to Vietnam, but also create an ecosystem of connection - training - clinical sharing between treatment lines to improve the effectiveness of patient care,” emphasized Dr. Bui Van Chinh.

At the workshop, experts also shared a lot of information related to this field. Specifically, Doctor CKI Dao Thuy Linh, Director of MammoCare Hanoi Breast Pathology Diagnosis Center - shared about 3D breast X-ray technology (Tomosynthesis).

“This technology allows for high-resolution 'slicing' of the breast structure, helping to detect early small lesions that 2D X-rays may miss, especially in women with dense breast tissue - thereby supporting more accurate diagnosis and significantly reducing the number of unnecessary biopsies,” Dr. Linh shared.

Meanwhile, Dr. Hoang Anh Dung, Deputy Head of Breast Surgery Department, Central Cancer Hospital, MammoCare Professional Consultant - presented a multimodal treatment model, emphasizing the effectiveness of breast conservation surgery after preoperative chemotherapy, stating that this method not only helps reduce invasive interventions but also improves the quality of life for patients.

Dr. Nguyen Dinh Hung, Director of Hanoi Department of Health, spoke at the workshop. Photo: MQ.

According to Dr. Nguyen Dinh Hung, Director of the Hanoi Department of Health: “This workshop contributes to updating new knowledge and technology in the diagnosis and treatment of breast cancer. This is a workshop model that needs to be replicated, not only helping to improve the professional capacity of the medical team but also creating an effective connection network between public and private medical facilities.”

Source: https://vietnamnet.vn/ung-dung-cong-nghe-de-dieu-tri-ca-the-hoa-ung-thu-vu-tai-viet-nam-2393434.html